Ledger.Open graph →
SEC Form D · filed March 27, 2020

Olema Pharmaceuticals, Inc

Offering
$45.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Andrew Rappaport · San Francisco, CADirectorFrank Mccormick · San Francisco, CAExec · DirectorGraham Walmsley · San Francisco, CADirectorCyrus Harmon · San Francisco, CAExec · DirectorDerek A. Mcdowell · Miami, FLDirectorSamuel B. Carr, Jr · ST. PAUL, MNDirectorCatherine L. Weyerhaeuser · ST. PAUL, MNExec · DirectorCourtland B. Cunningham · ST. PAUL, MNExec · DirectorGorjan Hrustanovich · San Francisco, CADirectorGlen T. Kacher · Palo Alto, CAExec · DirectorRobert M. Wenzell · Palo Alto, CADirectorAdam M. Hutt · New York, NYExec · DirectorAMH Equity Ltd · New York, NYDirectorGorjan Hrustanovich · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗